|
|
|
LifeScienceHistory.com - Check us out on Instagram
Washington Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing WashingtonLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Atossa Genetics Inc.
| | | Phone: | (206) 588-0256 | Fax: | (206) 430-1288 | Year Established: | 2009 | Employees: | 10 | Ticker: | ATOS | Exchange: | NASDAQ | Main Contact: | Stephen Quay, MD, Ph.D., Chairman & CEO | | Other Contacts: | Janet Rose Rea, M.S.P.H., VP Regulatory Affairs & Quality Kyle Guse, CFO & General Counsel
| | Company Description | Atossa Genetics is a healthcare company focused on the development and marketing of novel cellular and molecular diagnostic risk assessment products for breast cancer.
Atossa has received FDA clearance to market the Mammary Aspirate Specimen Cytology Test System (MASCT System™), a medical device which is designed to collect a small amount Nipple Aspirate Fluid (NAF) for diagnostic purposes. The test takes ten minutes, uses no radiation, and is painless. | |
|
|
|
|
|